Table 5

Summary of adverse events

Run-inBudesonide 3 mgBudesonide 9 mgPrednisolone 7.5 mgPlacebo
Evaluable patients14237353931
Exposure (days)2872268132552312
Number of adverse reactions (AE)9194978870
Number of patients with serious adverse reactions2022
Number (%) of patients with AE89 (63%)33 (89%)33 (94%)33 (85%)28 (90%)